Lupin shares surge 5% on receiving USFDA approval for Valbenazine Capsules
Lupin is a pharmaceutical company headquartered in Mumbai, India. While, it is the third-largest pharmaceutical company in the US by prescription. The company develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the US, India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.
